Antithyroperoxidase antibody-dependent cytotoxicity in autoimmune thyroid disease

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 3, 2008, Pages 929-934

  Rebuffat, Sandra A ^a   Nguyen, Brigitte ^a   Robert, Bruno ^b   Castex, Françoise ^a   Peraldi Roux, Sylvie ^a  

^a CNRS   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD32 ANTIGEN; CD64 ANTIGEN; CHROMIUM; FC RECEPTOR; FC RECEPTOR I; UNCLASSIFIED DRUG;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE THYROIDITIS; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; EFFECTOR CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN BINDING; THYROID CELL;

EID: 40849116190     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2042     Document Type: Article

References (31)

1. McLachlan SM, Prummel MF, Rapoport B 1994 Cell-mediated or humoral immunity in Graves' ophthalmopathy? Profiles of T-cell cytokines amplified by polymerase chain reaction from orbital tissue. J Clin Endocrinol Metab 78:1070-1074
2. McLachlan SM, Rapoport B 1993 Recombinant thyroid autoantigens: the keys to the pathogenesis of autoimmune thyroid disease. J Intern Med 234:347-359
3. Rapoport B, McLachlan SM 2001 Thyroid autoimmunity. J Clin Invest 108:1253-1259
4. Weetman AP 2004 Autoimmune thyroid disease. Autoimmunity 37:337-340
5. Doullay F, Ruf J, Codaccioni JL, Carayon P 1991 Prevalence of autoantibodies to thyroperoxidase in patients with various thyroid and autoimmune diseases. Autoimmunity 9:237-244
6. Bogner U, Schleusener H, Wall JR 1984 Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto's thyroiditis but not Graves' disease. J Clin Endocrinol Metab 59:734-738
7. Rodien P, Madec AM, Ruf J, Rajas F, Bornet H, Carayon P, Orgiazzi J 1996 Antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease: relationship to antithyroperoxidase antibodies. J Clin Endocrinol Metab 81:2595-2600
8. Metcalfe RA, Oh YS, Stroud C, Arnold K, Weetman AP 1997 Analysis of antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease. Autoimmunity 25:65-72
9. Guo J, Jaume JC, Rapoport B, McLachlan SM 1997 Recombinant thyroid peroxidase-specific Fab converted to immunoglobulin G (IgG) molecules: evidence for thyroid cell damage by IgG1, but not IgG4, autoantibodies. J Clin Endocrinol Metab 82:925-931
10. Wadeleux P, Winand-Devigne J, Ruf J, Carayon P, Winand R 1989 Cytotoxic assay of circulating thyroid peroxidase antibodies. Autoimmunity 4:247-254
11. Chiovato L, Bassi P, Santini F, Mammoli C, Lapi P, Carayon P, Pinchera A 1993 Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endocrinol Metab 77:1700-1705
12. Blanchin S, Estienne V, Durand-Gorde JM, Carayon P, Ruf J 2003 Complement activation by direct C4 binding to thyroperoxidase in Hashimoto's thyroiditis. Endocrinology 144:5422-5429
13. Weetman AP 2000 Graves' disease. N Engl J Med 343:1236-1248
14. Kasai K, Banba N, Motohashi S, Hattori Y, Manaka K, Shimoda SI 1996 Expression of monocyte chemoattractant protein-1 mRNA and protein in cultured human thyrocytes. FEBS Lett 394:137-140
15. Estienne V, Duthoit C, Reichert M, Praetor A, Carayon P, Hunziker W, Ruf J 2002 Androgen-dependent expression of FcγRIIB2 by thyrocytes from patients with autoimmune Graves' disease: a possible molecular clue for sex dependence of autoimmune disease. FASEB J 16:1087-1092
16. Ambesi-Impiombato FS, Parks LA, Coon HG 1980 Culture of hormone-dependent functional epithelial cells from rat thyroids. Proc Natl Acad Sci USA 77:3455-3459
17. Bogner U, Wall JR, Schleusener H 1987 Cellular and antibody mediated cytotoxicity in autoimmune thyroid disease. Acta Endocrinol Suppl (Copenh) 281:133-138
18. Davies J, Jiang L, Pan LZ, LaBarre MJ, Anderson D, Reff M 2001 Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FCγRIII. Biotechnol Bioeng 74:288-294
19. Idusogie EE, Wong PY, Presta LG, Gazzano-Santoro H, Totpal K, Ultsch M, Mulkerrin MG 2001 Engineered antibodies with increased activity to recruit complement. J Immunol 166:2571-2575
20. Barbin K, Stieglmaier J, Saul D, Stieglmaier K, Stockmeyer B, Pfeiffer M, Lang P, Fey GH 2006 Influence of variable N-glycosylation on the cytolytic potential of chimeric CD19 antibodies. J Immunother 29:122-133
21. Siberil S, de Romeuf C, Bihoreau N, Fernandez N, Meterreau JL, Regenman A, Nony E, Gaucher C, Glacet A, Jorieux S, Klein P, Hogarth MP, Fridman WH, Bourel D, Beliard R, Teillaud JL 2006 Selection of a human anti-RhD monoclonal antibody for therapeutic use: impact of IgG glycosylation on activating and inhibitory FcγR functions. Clin Immunol 118:170-179
22. Bogner U, Sigle B, Schleusener H 1988 Interferon-γ protects human thyroid epithelial cells against cell-mediated cytotoxicity. Immunobiology 176:423-431
23. McLachlan SM, Pegg CA, Atherton MC, Middleton SL, Dickinson A, Clark F, Smith BR 1987 The thyroid microenvironment in autoimmune thyroid disease: effects of TSH and lymphokines on thyroid lymphocytes and thyroid cells. Acta Endocrinol Suppl (Copenh) 281:125-132
24. Siberil S, Dutertre CA, Fridman WH, Teillaud JL 2007 FcγR: the key to optimize therapeutic antibodies? Crit Rev Oncol Hematol 62:26-33
25. Parkes AB, McLachlan SM, Bird P, Rees Smith B 1984 The distribution of microsomal and thyroglobulin antibody activity among the IgG subclasses. Clin Exp Immunol 57:239-243
26. Weetman AP, Black CM, Cohen SB, Tomlinson R, Banga JP, Reimer CB 1989 Affinity purification of IgG subclasses and the distribution of thyroid autoantibody reactivity in Hashimoto's thyroiditis. Scand J Immunol 30:73-82
27. Burton DR, Woof JM 1992 Human antibody effector function. Adv Immunol 51:1-84
28. Ravetch JV, Kinet JP 1991 Fc receptors. Annu Rev Immunol 9:457-492
29. Giancotti FG, Ruoslahti E 1999 Integrin signaling. Science 285:1028-1032
30. Williams MA, Solomkin JS 1999 Integrin-mediated signaling in human neutrophil functioning. J Leukoc Biol 65:725-736
31. Weetman AP, McGregor AM 1994 Autoimmune thyroid disease: further developments in our understanding. Endocr Rev 15:788-830